348 related articles for article (PubMed ID: 33100201)
1. Inhibition of Virulence Factors and Biofilm Formation of Acinetobacter Baumannii by Naturally-derived and Synthetic Drugs.
Bamunuarachchi NI; Khan F; Kim YM
Curr Drug Targets; 2021; 22(7):734-759. PubMed ID: 33100201
[TBL] [Abstract][Full Text] [Related]
2. Quorum-sensing system in Acinetobacter baumannii: a potential target for new drug development.
Saipriya K; Swathi CH; Ratnakar KS; Sritharan V
J Appl Microbiol; 2020 Jan; 128(1):15-27. PubMed ID: 31102552
[TBL] [Abstract][Full Text] [Related]
3. The role of quorum sensing, biofilm formation, and iron acquisition as key virulence mechanisms in Acinetobacter baumannii and the corresponding anti-virulence strategies.
Law SKK; Tan HS
Microbiol Res; 2022 Jul; 260():127032. PubMed ID: 35483311
[TBL] [Abstract][Full Text] [Related]
4. The Effect of Citric and Ascorbic Acids as Anti-Biofilm and Anti-Capsular Agents on Multidrug-Resistant Acinetobacter baumannii.
El-Soudany I; Attia N; Emad R; Rezk S
Med Princ Pract; 2024; 33(3):281-290. PubMed ID: 38359804
[TBL] [Abstract][Full Text] [Related]
5. 5-Episinuleptolide Decreases the Expression of the Extracellular Matrix in Early Biofilm Formation of Multi-Drug Resistant Acinetobacter baumannii.
Tseng SP; Hung WC; Huang CY; Lin YS; Chan MY; Lu PL; Lin L; Sheu JH
Mar Drugs; 2016 Jul; 14(8):. PubMed ID: 27483290
[TBL] [Abstract][Full Text] [Related]
6. Virulence characteristics of multidrug resistant biofilm forming Acinetobacter baumannii isolated from intensive care unit patients.
Zeighami H; Valadkhani F; Shapouri R; Samadi E; Haghi F
BMC Infect Dis; 2019 Jul; 19(1):629. PubMed ID: 31315572
[TBL] [Abstract][Full Text] [Related]
7. Anti-biofilm and anti-virulence effects of zerumbone against
Kim HR; Shin DS; Jang HI; Eom YB
Microbiology (Reading); 2020 Aug; 166(8):717-726. PubMed ID: 32463353
[No Abstract] [Full Text] [Related]
8. Antibiofilm and antivirulence potential of silver nanoparticles against multidrug-resistant Acinetobacter baumannii.
Hetta HF; Al-Kadmy IMS; Khazaal SS; Abbas S; Suhail A; El-Mokhtar MA; Ellah NHA; Ahmed EA; Abd-Ellatief RB; El-Masry EA; Batiha GE; Elkady AA; Mohamed NA; Algammal AM
Sci Rep; 2021 May; 11(1):10751. PubMed ID: 34031472
[TBL] [Abstract][Full Text] [Related]
9. Effect of secondary metabolite of Actinidia deliciosa on the biofilm and extra-cellular matrix components of Acinetobacter baumannii.
Tiwari V; Tiwari D; Patel V; Tiwari M
Microb Pathog; 2017 Sep; 110():345-351. PubMed ID: 28705748
[TBL] [Abstract][Full Text] [Related]
10. Antimicrobial and anti-biofilm potencies of dermcidin-derived peptide DCD-1L against Acinetobacter baumannii: an in vivo wound healing model.
Farshadzadeh Z; Pourhajibagher M; Taheri B; Ekrami A; Modarressi MH; Azimzadeh M; Bahador A
BMC Microbiol; 2022 Jan; 22(1):25. PubMed ID: 35026999
[TBL] [Abstract][Full Text] [Related]
11. Subinhibitory Concentrations of Trimethoprim and Sulfamethoxazole Prevent Biofilm Formation by Acinetobacter baumannii through Inhibition of Csu Pilus Expression.
Moon KH; Weber BS; Feldman MF
Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28674047
[No Abstract] [Full Text] [Related]
12. Phenotypic and molecular characterization of Acinetobacter baumannii isolates causing lower respiratory infections among ICU patients.
Jain M; Sharma A; Sen MK; Rani V; Gaind R; Suri JC
Microb Pathog; 2019 Mar; 128():75-81. PubMed ID: 30562602
[TBL] [Abstract][Full Text] [Related]
13. Adaptations of carbapenem resistant
Sharma S; Das A; Banerjee T; Barman H; Yadav G; Kumar A
J Med Microbiol; 2021 Mar; 70(3):. PubMed ID: 33739918
[No Abstract] [Full Text] [Related]
14. [Existence of Biofilm and Biofilm-Associated Virulence Genes in Multi-Drug Resistant Invasive Acinetobacter baumannii Isolates].
Altınok Ö; Boral B; Ergin A; Eser ÖK
Mikrobiyol Bul; 2020 Jan; 54(1):40-49. PubMed ID: 32050877
[TBL] [Abstract][Full Text] [Related]
15. Synergistic Inhibitory Effect of Polymyxin B in Combination with Ceftazidime against Robust Biofilm Formed by Acinetobacter baumannii with Genetic Deficiency in AbaI/AbaR Quorum Sensing.
Li Y; Wang B; Lu F; Ahn J; Zhang W; Cai L; Xu J; Yin Y; Cao Q; Ren Z; He X
Microbiol Spectr; 2022 Feb; 10(1):e0176821. PubMed ID: 35196792
[TBL] [Abstract][Full Text] [Related]
16. [Influence of poly-β-1-6-N-acetylglucosamine on biofilm formation and drug resistance of Acinetobacter baumannii].
Guo H; Xiang J
Zhonghua Shao Shang Za Zhi; 2015 Feb; 31(1):45-7. PubMed ID: 25876639
[TBL] [Abstract][Full Text] [Related]
17. Antimicrobial activity of novel chalcones and modulation of virulence factors in hospital strains of Acinetobacter baumannii and Pseudomonas aeruginosa.
Ušjak D; Ivković B; Božić DD; Bošković L; Milenković M
Microb Pathog; 2019 Jun; 131():186-196. PubMed ID: 30980878
[TBL] [Abstract][Full Text] [Related]
18. Attenuation of Acinetobacter baumannii virulence by inhibition of polyphosphate kinase 1 with repurposed drugs.
Gautam LK; Sharma P; Capalash N
Microbiol Res; 2021 Jan; 242():126627. PubMed ID: 33131985
[TBL] [Abstract][Full Text] [Related]
19. Acinetobacter baumannii displays inverse relationship between meropenem resistance and biofilm production.
Perez LR
J Chemother; 2015 Feb; 27(1):13-6. PubMed ID: 24621167
[TBL] [Abstract][Full Text] [Related]
20. [Investigation of the virulence factors of multidrug-resistant Acinetobacter baumannii isolates].
Eraç B; Yılmaz FF; Hoşgör Limoncu M; Oztürk I; Aydemir S
Mikrobiyol Bul; 2014 Jan; 48(1):70-81. PubMed ID: 24506717
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
